Fibroblast growth factor-2 induces the activation of Src through Fes, which regulates focal adhesion disassembly. by Kanda Shigeru et al.
 1
Fibroblast growth factor-2 induces the activation of Src through Fes, which 
regulates focal adhesion disassembly 
 
Shigeru Kanda1, 4, 5, Yasuyoshi Miyata2, Hiroshi Kanetake2, and Thomas E. Smithgall3 
1Department of Molecular Microbiology and Immunology, Division of Endothelial Cell 
Biology, and 2Department of Urology, Nagasaki University Graduate School of Biomedical 
Science, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan, and 3Department of Molecular Genetics 
and Biochemistry, University of Pittsburgh School of Medicine, E1240 Biomedical Science 
Tower, Pittsburgh, PA 15261  
 
4Corresponding author; 
Shigeru Kanda, M.D., Ph.D., 
Department of Molecular Microbiology and Immunology, 
Division of Endothelial Cell Biology, 




Phone: +81 95 849 7340 




National Hospital Organization, Nagasaki Hospital 
41-6 Sakuragi,  
Nagasaki 850-8523 
Japan 
Phone: +81 (0)95 823-2261 
 2
Fax: +81 (0)95 828-2616 
E-mail: skanda-jua@umin.net 
 
Abbreviations: FGF, fibroblast growth factor; FA, focal adhesion; FAK, focal adhesion kinase; 
siRNA, small interfering RNA; CCD, coiled-coil domain; YFP, yellow-fluorescent protein; 




        Cell migration is regulated by focal adhesion (FA) turnover. Fibroblast growth factor-2 
(FGF-2) induces FA disassembly in the murine brain capillary endothelial cell line, IBE, 
leading to FGF-2-directed chemotaxis. We previously showed that activation of Src and Fes by 
FGF-2 was involved in chemotaxis of IBE cells. In this study, we examined the interplay 
between Src and Fes. FGF-2 treatment decreased the number of FA in IBE cells, but not in cells 
expressing dominant-negative Fes (denoted KE5-15 cells). FGF-2 induced the activation of 
Src and subsequent binding to and phosphorylation of Cas in IBE cells, but not in KE5-15 cells. 
Focal adhesion kinase (FAK) activation and tyrosine phosphorylation by Src was also delayed 
in KE5-15 cells compared to parental cells. FGF-2 induced activation of Src within FA in IBE 
cells, but not in KE5-15 cells. Down-regulation of Fes or FAK using small interfering RNA 
diminished Src activation by FGF-2 within FA. These findings suggest that activation of Fes by 
FGF-2 enhances FAK-dependent activation of Src within FA, promoting FGF-2-induced 
disassembly of focal adhesions.  
 




 Angiogenesis is a prerequisite for both normal development as well as 
pathophysiological processes, such as collateral formation following occlusion of arteries, 
diabetic retinopathy, and solid tumor growth [1-3]. A number of endothelial cell responses 
must be integrated for efficient angiogenesis, including proliferation, differentiation and 
migration [4]. Cell migration is coordinated by signaling events involving both growth factor 
receptors and integrins [5-7]. Many studies have emphasized the contribution of dynamic 
assembly and disassembly of focal adhesions to this response. Although multiple signaling 
molecules are incorporated within focal adhesions (FA), focal adhesion kinase (FAK) and Src 
play fundamental roles in focal adhesion turnover [8-10].  
 Fibroblast growth factors (FGFs) are important regulators of angiogenesis both in 
vitro and in vivo [11, 12]. To date, 23 distinct forms of FGF have been identified [13]. 
Prototypical FGFs, such as FGF-1 and FGF-2, are the most thoroughly studied FGFs in relation 
to angiogenesis. Four structurally-related receptor tyrosine kinases for FGFs have been 
reported, denoted FGF receptors (FGFR) 1 to 4 [14]. Of these, both FGFR-1 and 2 are 
expressed in endothelial cells, where they induce Src activation and chemotaxis [15-17]. Src 
has also been implicated in FGF-regulated migration and proliferation of fibroblasts [18-20]. 
We have previously shown that Fes, a non-receptor protein tyrosine kinase distinct from Src, 
also contributes to FGF-2-induced chemotaxis and differentiation of capillary endothelial cells 
[21]. In this study, we provide evidence that Fes activity is required for FGF-2-induced 
activation of Src and focal adhesion disassembly, providing the first mechanistic link between 
these protein-tyrosine kinases in FGF-induced regulation of vascular endothelial cell behavior.  
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Materials and methods 
 
Materials 
 Anti-vinculin monoclonal antibody (clone hVIN-1), anti-FLAG monoclonal 
antibody (M2), and anti--actin monoclonal antibody (clone AC-74) were purchased from 
Sigma Chemical Company, St. Louis, MO. Anti-Src polyclonal antibodies (N-16 and SRC2), 
anti-Fes polyclonal antibody (N-19), anti-Cas polyclonal antibody (C-20), and non-targeting 
control small interfering RNA (siRNA) were purchased from Santa Cruz Biotechnologies, 
Santa Cruz, CA. Anti-pY418 Src, anti-pY529 Src, anti-pY397 FAK, and anti-pY861 FAK 
polyclonal antibodies were obtained from BioSource International, Inc., Camarillo, CA. 
Anti-phosphotyrosine monoclonal antibody (clone 4G10) and anti-FAK monoclonal antibody 
(clone 4.47 for immunoprecipitation) were purchased from Upstate Cell Signaling Solutions, 
Lake Placid, NY. Anti-FAK monoclonal antibody (clone 77 for immunostaining and 
immunoblotting) was obtained from BD Bioscience, San Jose, CA. HiPerFect transfection 
reagent, Alexa Fluor 555-labeled negative control siRNA 
(5’-UUCUUCGAACGUGUCACGU-3’), two mouse FAK siRNAs 
(5’-GGUCCAAUGACAAGGUAUA-3’ and 5’-GAUUAUUAAAGGUCUUUCA3’), and two 
mouse Fes siRNAs (5’-GCCUGAGAAAGACGUACAA-3’ and 
5’-GGAUGGAGACAAGGCCAAA-3’) were purchased from Qiagen K.K., Tokyo, Japan. 
 
Cells and culture 
 Parental IBE cells [15] and IBE cell lines expressing kinase-inactive mutant Fes 
(denoted KE5-15 cells) were cultured as described elsewhere [21]. A stable IBE cell line 
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expressing kinase-inactive Src (denoted KDSrc-2 cells), which exhibits a dominant negative 
effect on FGF-2-induced activation of Src, was cultured as described [17].   
 
Transfection of siRNA 
 IBE cells were transfected with siRNA using the HiPerFect reagent. To examine the 
transfection efficiency, Alexa Fluor 555-labeled control siRNA was tranfected into IBE cells 
and on the next day, cells were washed, fixed with paraformaldehyde, and examined for 
fluorescence. To downregulate Fes, IBE cells were grown in 10 cm dishes and transfected with 
control siRNA or mixture of two siRNA for Fes and cultured for two days. Cells were then 
suspended in serum-free medium and counted; 80% of the cells were used for assessment of 
Fes expression by immunoprecipitation followed by immunoblotting while the remaining 20% 
were used for indirect immunofluorescent staining for vinculin and activated Src. To 
downregulate FAK, IBE cells were transfected with a mixture of two FAK siRNAs or control 
siRNAs in 6-well plates. Two days later, cells were used either for indirect immunofluorescent 
staining for vinculin and activated Src or lysed for the assessment of FAK and -actin 
expression by immunoblotting.  
 
Immunoprecipitation and immunoblotting  
 Immunoprecipitation and immunoblotting were performed as described before [22].  
In brief, cells suspended in serum-free medium were seeded onto fibronectin-coated dishes and 
cultured for various periods in the presence or absence of 20 ng/ml of FGF-2. Cells were lysed 
in Triton X-100 lysis buffer and kinase or focal adhesion proteins were immunoprecipitated 
and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).  After transfer onto 
 7
polyvinylidene difluoride membranes (Millipore, Bedford, MA), the blots were probed with 
antibodies as indicated in the Figures. Prior to reprobing, blots were stripped as described 
previously [21]. For the FAK blots, band intensities were determined from scanned images of 
the blots using NIH Image (version 1.64). The relative ratio of FAK tyrosine phosphorylation 
was calculated as the ratio of the phospho-FAK signals divided by the corresponding FAK 
protein signal; each value was then normalized to the ratio obtained from untreated, suspended 
cells. 
 
Indirect immunofluorescent staining 
 Indirect immunofluorescent staining was performed as described previously [23]. 
Cells were seeded onto the surface of fibronectin-coated coverslips with or without FGF-2 (20 
ng/ml) and cultured for indicated periods. Cells were washed with PBS, fixed with 3.7% 
paraformaldehyde, and permeabilized with 0.1% Triton X-100. To visualize FA, cells were 
stained with an anti-vinculin monoclonal antibody. To examine FA turnover, vinculin-positive 
spots were counted in at least 200 cells for each condition. For co-localization experiments, 
cells were seeded onto fibronectin-coated coverslips and cultured for 2 h with or without 
FGF-2. Cells were fixed and stained with the anti-vinculin monoclonal antibody (mouse) and 
anti-Fes polyclonal antibody (goat) or anti-pY418 Src polyclonal antibody (rabbit). Mouse 
primary antibodies were visualized with corresponding secondary antibodies labeled with 
Alexa Fluor 488, while goat or rabbit primary antibodies were recognized with specific 
secondary antibody-Alexa Fluor 555 conjugates. 
 
In vitro kinase assay  
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 The in vitro kinase assay for Src was described previously [16]. In brief, cells were 
seeded onto fibronectin-coated wells of 6-well plates with or without 20 ng/ml FGF-2. After 2 
h, cells were lysed in NP40 lysis buffer supplemented with 0.1% 2-mercaptoethanol. Src was 
immunoprecipitated and incubated in kinase buffer supplemented with acid-denatured enolase 
and [-32P]ATP, followed by SDS-PAGE. Gels were washed, fixed, treated with 1 M KOH to 
remove phosphorylated serine residues, and imaged using a BAS 5000 Image Analyzer 
followed by exposure to X-ray film. 
 
Statistical analysis 
 Data are presented as the mean ± SD. Differences between two groups were 
examined by Mann-Whitney’s U test. A P value less than 0.05 denoted the presence of a 




FGF-2 induces disassembly of FA in IBE cells 
 We have previously shown that Fes activity was involved in FGF-2-directed 
chemotaxis of IBE cells [21]. FA disassembly is critical for cell migration, and 
FGF-2-treatment of IBE cells decreases the number of FA [23]. To elucidate the role of Fes in 
FA turnover by IBE cells, we studied the number of FA in IBE cells expressing 
dominant-negative Fes following culture on a fibronectin-coated surface.  As shown in Fig. 1, 
control IBE cells formed FA in response to plating on fibronectin, and the number of FA was 
decreased in the presence of FGF-2 both 1 h and 2 h later. In contrast, IBE cells expressing 
dominant-negative Fes (denoted KE5-15 cells) formed FA in greater numbers than parental 
IBE cells and FGF-2 treatment did not affect the number of FA.  This result suggests that Fes is 
required for FGF-2-induced disassembly of FA in these cells. Unlike FA formation, 
FGF-2-induced stress fiber formation was not altered between the control and KE5-15 IBE cell 
lines (data not shown). 
 
FGF-2 induces Src activation, which is dependent on Fes activity 
 To determine the possible interplay between Fes and FAK/Src signaling in FA 
turnover, we first examined the kinase activity of Src in FGF-2-treated parental IBE cells and 
KE5-15 cells, which express dominant-negative Fes. As shown in Fig. 2 A, Src activity was 
increased by FGF-2-treatment in control IBE cells but not in KE5-15 cells, suggesting that Fes 
kinase activity is required for FGF-2-induced Src activation. Consistent with this observation, 
both basal and FGF-2-induced Src autophosphorylation at Tyr 418 were blocked in KE5-15 
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cells (Figure 2 B, lower panels). We also examined whether the presence of kinase-defective 
Fes affected interaction of endogenous Src with p130 Cas, an adaptor protein involved in FA 
turnover [24]. As shown in Figure 2 B, co-precipitation of Cas with Src was dramatically 
reduced in the KE5-15 cells, which is likely due to the block in Src activity resulting from the 
presence of dominant-negative Fes. The tyrosine phosphorylation of Cas in KE5-15 cells was 
slightly elevated by FGF-2-treatment. However, the amount of Src-bound Cas was extremely 
low in KE5-15 cells compared to the control cell line. Therefore, it seems likely that this 
elevation of Cas tyrosine phosphorylation was unable to compensate for the loss of Src-Cas 
signaling required for FA disassembly in the KE5-15 cells. 
 Ligation of integrins induces FAK autophosphorylation at Y397, which leads to its 
activation and creates a binding site for Src via its SH2 domain [8]. Binding to FAK may 
contribute to Src activation by disrupting the inhibitory interaction between its SH2 domain 
and tyrosine-phosphorylated tail [25]. Once bound and activated, Src phosphorylates FAK at 
Y861 [26]. To determine whether Fes affects the interplay of Src and FAK, we examined the 
kinetics of FAK activation and phosphorylation by Src in parental IBE cells and KE5-15 cells. 
As shown in Fig. 3, FAK was rapidly phosphorylated on Y397 following adhesion to 
fibronectin in control IBE cells, and phosphorylation of this site decreased 2 h after seeding. 
FGF-2 did not increase the phosphorylation of Y397 further and in fact appeared to hasten its 
dephosphorylation. By contrast, phosphorylation of Y397 was weak in KE5-15 cells at 30 min 
and was slightly increased at 2 h, suggesting that Y397 phosphorylation is delayed by the 
presence of the Fes dominant-negative mutant. FGF-2 treatment did not affect the 
phosphorylation of FAK Y397 phosphorylation in KE5-15 cells. Adhesion-induced 
phosphorylation of FAK Y861 was also readily observed after 30 min in parental IBE cells, 
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although this site remained phosphorylated at 2 h and was prolonged in response to FGF-2 
treatment, suggesting that FGF-2-activated Src may be involved. Although 
adhesion-dependent phosphorylation of FAK Y861 occurred with similar kinetics in KE5-15 
cells, the FGF-2-induced increase in phosphorylation at 2 h was not observed. Together, these 
data implicate Fes in the adhesion-dependent activation of FAK through Src.   
 
FGF-2 activates Src within FA, which is dependent on Fes and FAK 
 To elucidate the role of Fes and FAK in FGF-2-induced activation of Src, we 
employed siRNA technology. Using Alexa Fluor 555-labeled negative control siRNA, we first 
established conditions that allowed for a transfection efficiency of more than 90% in IBE cells 
(data not shown). Next, we transfected IBE cells with either control siRNA or Fes siRNA. Two 
days later, cells were seeded onto fibronectin-coated culture plates and Fes expression as well 
as activation of Src at FA were examined. As shown in Fig. 4 A, the Fes siRNA efficiently 
downregulated Fes protein expression, while the contol siRNA was without effect. We then 
examined the localization of Fes in IBE cells. In cells transfected with control siRNA, Fes 
localized to the cytoplasm as well as FA (Fig. 4 B). We also determined the specificity of 
immunofluorescent staining with the Src phosphospecific antibody, pY418. Our previous study 
has shown that FGF-2 activated Src within FA, which was followed by the activation of 
mitogen-activated protein kinase within FA [17]. As shown in Fig. 4 C, focal adhesions in 
FGF-2-treated mock-transfected cells stained positively with the anti-pY418 Src antibody, 
indicating that active Src is present within FA. In contrast, the antibody failed to detect 
activated Src in FA of FGF-2-treated cells expressing dominant-negative Src (KDSrc-2 cells). 
Fig. 4D shows that Src activation in focal adhesions was also completely blocked in cells 
 12
transfected with Fes siRNA, indicating that Fes is required for FGF-2-induced Src activation 
within FA. As a control, we also determined the effect of FAK knock-down on Src activation 
within FA. As shown in Fig. 5, suppression of FAK protein expression with siRNA also 




 In this study, we provide new evidence that the c-Fes tyrosine kinase may regulate 
FA turnover in IBE capillary endothelial cells by modulating Src and FAK signaling. Several 
previous studies have established that oligomerization is essential for the kinase and biological 
activities of c-Fes. Importantly, kinase-dead Fes has been shown to form mixed oligomers with 
wild-type Fes and suppresses its autophosphorylation [27]. Directly relevant to this study is our 
prior observation that expression of kinase-inactive Fes abolished FGF-2-induced 
autophosphorylation of endogenous Fes in IBE cells, suggesting that kinase-inactive Fes 
oligomerized with endogenous Fes leading to the blockade of FGF-2-directed chemotaxis in 
this system [21]. Experiments with a dominant-negative mutant provide evidence that Fes 
activity is required for Src activation by FGF-2, which in turn regulates Src interaction with the 
FA protein p130 Cas (Fig. 2). Perhaps most striking was the observation that targeted 
knock-down of Fes protein expression with siRNA almost completely blocked 
FGF-2-regulated Src activation within FA (Fig. 4). The magnitude of this effect was virtually 
identical to that observed when FAK itself was suppressed with siRNA (Fig. 5).  
 In parental IBE cells, FAK activation (autophosphorylation of Y397) was observed 
30 minutes after plating on fibronectin and was independent of FGF-2-treatment. This initial 
rapid activation was followed by dephosphorylation of this tyrosine residue at 2 h. In addition, 
we observed continuous, strong phosphorylation of Y861, a known phosphorylation site for 
c-Src on FAK (Fig. 3). These kinetics are consistent with the finding that FAK activation leads 
to the recruitment and activation of Src by disruption of the intramolecular inhibitory 
interaction between its SH2 domain and C-terminal tail [25]. In contrast, maximal 
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phosphorylation of Y397 occurred much later in the presence of dominant-negative Fes, and 
overall Y861 phosphorylation was reduced 2 h after fibronectin plating in the presence and 
absence of FGF-2. From these results, it is clear that autophosphorylation of FAK was largely 
regulated by cell adhesion to fibronectin, and was also affected by Fes kinase activity. However, 
Src activation and subsequent phosphorylation of FAK at 2 h after plating was dependent on 
FGF-2-treatment in IBE cells, but not in KE5-15 cells. Together, these observations suggest a 
model in which FGF-2-induced Fes activation contributes to Src activation through FAK in FA, 
promoting their disassembly (Fig. 6). Indeed, dominant-negative Fes prevents the FA 
disassembly normally observed following treatment of IBE cells with FGF-2 (Fig. 1). 
                 While the direct biochemical target for Fes in FA is not clear, FAK appears to be a 
strong candidate based on the effect of dominant-negative Fes on the kinetics of FAK 
activation in IBE cells. One conclusion is that dominant-negative Fes may prevent 
phosphorylation of FAK by endogenous Fes in response to integrin engagement, thus delaying 
FAK activation. Interestingly, downregulation of endogenous Fes protein levels by siRNA in 
IBE cells did not decrease the level of FAK Y397 phosphorylation, supporting a requirement 
for the presence of the Fes protein in the inhibitory mechanism (data not shown). However, 
downregulation of Fes by siRNA did suppress FA formation. Taken together, these 
observations suggest that the presence of the Fes protein provides a necessary scaffolding 
function to recruit additional signaling partners required for FA turnover in response to FAK 
activation. This hypothesis is currently under investigation.  
 In summary, the present study emphasizes the significance of Fes in an important 
angiogenic response of endothelial cells, namely migration in response to FA disassembly. Fes 
also acts as a mediator of angiogenic stimuli promoted by angiopoietins, sonic hedgehog, and 
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stromal cell-derived factor-1 [22, 28-30]. Fes may represent a previously unrecognized 
endothelial cell-specific molecular target for anti-angiogenic therapy. Antagonists of Fes 
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Fig. 1. FGF-2-treatment decreases the number of focal adhesions (FA) in parental IBE cells, 
but not in dominant-negative Fes-expressing cells (KE5-15 cells). Cells were seeded onto 
fibronectin-coated coverslips and cultured in serum-free medium in the presence or absence of 
20 ng/ml FGF-2 for the indicated periods. Cells were fixed and FAs were visualized by indirect 
immunofluorescent staining with an anti-vinculin antibody. Values are expressed as the number 
of focal adhesions/cell ± SD for at least 200 cells. *; P < 0.05. Representative images are shown 
on the left. 
 
Fig. 2. (A) FGF-2 activates Src in IBE cells, but not in KE5-15 cells. Cells were suspended in 
serum-free medium and seeded onto fibronectin-coated wells of 6-well plates. Cells were 
cultured for 2 h in the presence or absence of 20 ng/ml of FGF-2 and lysed. Src was 
immunoprecipitated from 80% of lysates and in vitro kinase assay was performed. Enolase was 
used as a substrate. The remaining 20% of each lysate was to assess Src levels by 
immunoblotting. Comparable data were obtained from two independent experiments. (B) Cells 
suspended in serum-free medium were seeded onto fibronectin-coated 10 cm dishes and 
cultured for 2 h in the presence or absence of 20 ng/ml of FGF-2. Cells were lysed and Src was 
immunoprecipitated followed by immunoblotting for associated Cas. Blots were stripped and 
reprobed to reveal Cas tyrosine phosphorylation (pTyr), Src protein levels, and Src 
autophosphorylation (pY418). Comparable data were obtained from two independent 
experiments. 
 23
Fig. 3. Kinetic study of the tyrosine phosphorylation of FAK. Cells were suspended in 
serum-free medium and either kept suspended for 15 min (susp) or seeded onto 
fibronectin-coated wells of 6 cm dishes to promote adhesion (ad). Cells were cultured for 30 
min or 120 min in the presence or absence of 20 ng/ml of FGF-2 and lysed. FAK was 
immunoprecipitated and probed for phosphotyrosine content by immunoblotting. Blots were 
stripped and reprobed with FAK antibodies to control for FAK recovery. Relative 
phosphorylation of FAK (the ratio of an intensity of phospho-FAK/total FAK estimated by 
quantitative densitometry) was calculated and normalized to the ratios observed with untreated, 
suspended cells (far left lanes). Similar results were obtained from two independent 
experiments. 
 
Fig. 4. Downregulation of Fes by siRNA abolishes FGF-2-induced Src activation in FA. (A) 
Fes siRNA-treatment downregulates endogenous Fes in IBE cells. IBE cells grown in 10 cm 
dishes were treated with either control siRNA (10 nM) or a mixture of two siRNAs for mouse 
Fes (10 nM each) and cultured for 48 h. Cells were harvested, counted, and 80% of cells were 
used for the determination of Fes expression and the remaining 20% of cells were used for the 
expression of -actin or indirect immunofluorescent staining (B and C). (B) Fes is 
downregulated in IBE cells treated with Fes siRNA. Focal adhesions were visualized by 
immunostaining with antibodies to vinculin (arrowheads). (C) Anti-pY418 Src 
phosphospecific antibody detects FGF-2-activated Src within FA. Mock cells (empty 
vector-transfected cells) or a stable cell line expressing kinase-inactive Src (denoted KDSrc-2 
cells) were seeded onto fibronectin-coated coverslips with or without FGF-2 at 20 ng/ml and 
cultured for 2 h. Cells were fixed and double stained with anti-vinculin antibody and 
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anti-pY418 Src antibody which recognizes the phosphorylated activation loop of c-Src. (D) Src 
is activated in FA by FGF-2 in IBE cells treated with control siRNA, but not in cells treated 
with Fes siRNA. Arrowheads indicate the FA. Active Src was visualized by immunostaining 
with the anti-pY418 antibody. Similar results were obtained in two independent experiments. 
 
Fig. 5. Downregulation of FAK by siRNA abolishes FGF-2-induced Src activation in FA. (A) 
Downregulation of FAK by siRNA. IBE cells grown in wells of 6-well plates were treated with 
either control siRNA (5 nM) or the mixture of two siRNA for FAK (1 nM or 5 nM each). Two 
days later, cells were examined for the expression of FAK by immunoblotting.  (B) Cells from 
part A were examined by indirect immunofluorescent staining for FA with vinculin antibodies 
and for active Src with phosphospecific antibodies to Tyr 418 as described in the legend to Fig. 
4. Arrowheads indicate the FA. Similar results were obtained from two independent 
experiments. 
 
Fig. 6. Proposed signaling pathways leading to FGF-2-mediated migration of IBE cells. FAK 
activation is largely regulated by the adhesion of cells to fibronectin. FGF-2 activates Fes and 
Fes modulates Src activation by FAK. Active Src associates with tyrosine phosphorylated Cas, 
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